Services

Specialized consulting offerings for Pharma, Biotech, CDMO, and Private Equity

Whether you are an emerging Biotech or Pharma company, a drug delivery firm, a CRO or a CDMO, or a Private Equity Institution, I am specialized in strategic growth and come across many customers in the field that struggle to realize sustainable revenue growth. Growth can be realized organically through investments, operational excellence or other initiatives, or it may need to come from (inorganic) acquisitions; I can support making these choices and defining related programs. My offering is based on three key parallels / directions:


  • Develop and implement sustainable growth strategies
  • Lead commercial organizations, complex negotiations & challenge the status- quo
  • Idea generation, Investment concepts, M&A target assessments


Many discussions I have had over past months, taught me that diligent execution of a strategy is increasingly difficult to maintain/uphold, as tactical moves (e.g. adapting to politics or other short-term dynamics in daily life), disturb momentum and often disable overall strategy implementation. I look forward to bringing value to both new and existing customer relationships in making the world healthier, cleaner and safer.

Develop and Implement Sustainable Growth Strategies

This offering can be fully customized from initiating a growth strategy together with client organization in a number of workshops to the actual implementation of such strategy. As most successful executives indicate: 80% of a strategy depends on its implementation, it is crucial to maintain course during implementation and not to deviate because of today's short- term distractors. I am happy to discuss and customize your program in this area.

Lead Commercial Organizations, Complex Negotiations & Challenge the Status-Quo

The commercial offering can be fully customized from leading or supporting a commercial organization on ad-interim basis, to actual hands-on work in business development.

Janssen Pharma Consult also has developed commercial trainings, based on best practices in industry. Training sessions can be supported in face-to-face workshops, or virtually online.

  • Module I: Understanding the customer

    • Market Development
    • Drug Development
    • Customer Segmentation
    • Value Proposition / Benefits of using CDMO’s
    • Account Segmentation: Key Account vs. Business Development

  • Module II: Winning the business

    • Business Development, Sales and Customer Focus
    • Proposal Management and Accountability towards Business Development / Account Managers
    • Negotiation
    • Strategic Account Penetration
    • Advanced Strategic Deals

  • Module III: Commercial Team Management

    • BD Team Management
    • Motivating & Incentive Approaches

  • Module IV: Technical Awareness Trainings

    • Chemical Manufacturing
    • Biologics Manufacturing

Idea Generation, Investment Concepts, M&A Target Assessments

This offering can be fully customized from fully undefined idea generation, an in-depth market analysis of a pre-generated idea/target list, through supporting a complete due diligence. I am happy to discuss your ideas and customize your program accordingly.

Project Examples



  • CODIS - Strategy & Business Development

    Immediately following the acquisition of the Haverhill (UK) site by Particle Dynamics in which CODIS was formed, JPC supported the market positioning of the extended company service offering with an ad-interim strategic business development mandate (Introducing CODIS at relevant customers, improving customer awareness on the new company, analysis of alternative options to further strengthen the service offering and grow CODIS — e.g. acquisition opportunities).

  • Global Leading CDMO - Sustainable Growth

    For a globally leading CDMO: Commercially secured investments in ADC payload facilities (2018 & 2020) and dedicated antibody drug conjugate bioconjugation suites (2020), growing a new customer into a strategic key account. Supported and governed the realization of two High Potency API production lines (2019). 

  • Global Leading CDMO - M&A

    Assessed many different API development & manufacturing facilities and initiated due diligence for several potential acquisitions.

    Represented the Small Molecules Division in acquisitions. 

  • Global Consulting - Organizational Transformation

    On behalf of a global consulting company: shaped, optimized and ran an IT service department for a global lifesciences company , handing it into the parent organization upon completion.

Publications &Communications